samedan logo
 
 
spacer
home > epc > summer 2003 > bioterrorism: preparing for the worst.
PUBLICATIONS
European Pharmaceutical Contractor

Bioterrorism: Preparing For the Worst.

Following the terrorist attacks of September 11th and the bioterrorism attack using anthrax-tainted letters in the United States, the perceived risk of another, larger-scale bioterrorism attack has escalated sharply. Rather than a small, contained incident such as the anthrax letters, experts fear a larger aerosolised release of a biological weapon, which could result in high morbidity and mortality. It is incumbent upon the health care and public health systems to be as prepared as possible for a potential event.

Bioterrorism is unlike other terrorist activity and natural disasters. Identification of the event will most likely be delayed and the primary responders and response activities are different. Although the preparation and response for bioterrorism has many similarities to other disasters, there are also unique challenges.

How a bioterrorism event would unfold will depend a great deal on the following factors:

Whether the attack is covert or overt

How soon the attack is identified

Which agent is utilised

The scope of the release

The easiest way to explain the differences is to provide examples of different potential bioterrorism events and describe the possible outcomes. One of the best-case scenarios would be a small, announced attack utilising a bacterial agent for which we have identified effective antibiotics therapy and/or vaccination. For example, although the anthrax letters caused panic and fear, they caused very few casualties when compared to the potential damage inflicted upon a community if the same amount of agent had been aerosolised and released unannounced.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Terri Rebmann, Infectious Disease Specialist for the Center for the Study of Bioterrorism and Emerging Infections (CSB&EI) at Saint Louis University, School of Public Health

Terri Rebmann is the Infectious Disease Specialist at the Center for the Study of Bioterrorism and Emerging Infections (CSB&EI) at Saint Louis University, School of Public Health. She has been with the Center since its inception in July 2000. She is a Clinical Nurse Specialist with a Masters in Nursing, with an emphasis in infectious diseases. In addition, she is certified in infection control. Her past work experience includes research and clinical practice with HIV/AIDS patients and hospital infection control.

In her current position with CSB&EI, she is responsible for the development of bioterrorism training and quick reference materials for health care and public health professionals. She is a member of the national APIC Bioterrorism Working Group and a task force at Saint Louis University, which recently went to Israel to study disaster preparations from the Hadassah Medical System. Terri continues to publish and lecture on bioterrorism and infection control practices on a national basis, including participation in bioterrorism exercises and development of bioterrorism-related websites.

spacer
Terri Rebmann
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Global Clinical Outsourcing Partnerships

26-27 March 2009, Mariott Hotel, Brussels

This Jacob Fleming event is designed to promote direct business. It features a two-day educational session with case studies, presentations and interactive sessions. This forum offers networking and the forging of new business partnerships in a unique business-driven environment.
More info >>

 
News and Press Releases

INTERLAB growing at a rate of 35%

24th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement